Scientists test supercharged cord blood cells as new weapon against tough lung cancers
NCT ID NCT05334329
Summary
This early-stage study is testing a new type of cell therapy for people with advanced non-small cell lung cancer that has spread and no longer responds to standard immunotherapy. Researchers are giving patients specially modified immune cells (called NK cells) taken from umbilical cord blood, which are designed to better find and kill cancer cells. The main goals are to find a safe dose and see if this approach, given with or without an existing immunotherapy drug (atezolizumab), can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chao Family Comprehensive Cancer Center University of California, Irvine
Orange, California, 92868, United States
Conditions
Explore the condition pages connected to this study.